Antibiotic transformation in an anaerobic membrane bioreactor linked to membrane biofilm microbial activity

The introduction of influent sulfamethoxazole loads induces changes in the removal pathways of sulfamethoxazole in vertical flow constructed wetlands featuring hematite substrate

High frequent detection of sulfamethoxazole (SMX) in wastewater cannot be effectively removed by constructed wetlands (CWs) with a traditional river sand substrate. The role of emerging substrate of hematite in promoting SMX removal and the effect of influent SMX loads remain unclear. The removal efficiency of SMX in hematite CWs was significantly higher than that in river sand CWs by 12.7-13.8% by improving substrate adsorption capacity, plant uptake and microbial degradation. With increasing influent SMX load, the removal efficiency of SMX in hematite CWs slightly increased, and the removal pathways varied significantly. The contribution of plant uptake was relatively small (< 0.1%) under different influent SMX loads. Substrate adsorption (37.8%) primarily contributed to SMX removal in hematite CWs treated with low-influent SMX. Higher influent SMX loads decreased the contribution of substrate adsorption, and microbial degradation (67.0%) became the main removal pathway. Metagenomic analyses revealed that the rising influent load increased the abundance of SMX-degrading relative bacteria and the activity of key enzymes. Moreover, the abundance of high-risk ARGs and sulfonamide resistance genes in hematite CWs did not increase with the increasing influent load. This study elucidates the potential improvements in CWs with hematite introduction under different influent SMX loads.

Pyrrhotite-dependent microbial reduction and magnetic separation for efficient vanadium detoxification and recovery in contaminated aquifer

Microbial reduction under anaerobic condition is a promising method for remediating vanadate [V(V)] contamination in aquifers, while V(V) may be re-generated with redox fluctuations. The inability to remove vanadium after remediation has become a key issue limiting bioremediation. In this study, we proposed the use of pyrrhotite, a natural mineral with magnetic properties, to immobilize V(V) to insoluble V(IV) under microbial action and remove vanadium from the aquifer using a magnetic field, which could avoid the problem of V(V) recontamination under redox fluctuating conditions. Up to 49.0 ± 4.7 % of vanadium could be removed from the aquifer by the applied magnetic field, and the vanadium in the aquifer after the reaction was mainly in the acid-extractable and reducible states. pH had a strong effect on the magnetic recovery of V(V), while the influence of initial V(V) concentration was weak. Microbial community structure analysis showed that Thiobacillus, Proteiniphilum, Fermentimonas, and Desulfurivibrio played key roles for V(V) reduction and pyrrhotite oxidation. Structural equation model indicated the positive correlation between these genera with the magnetic recovery of vanadium. Real time-qPCR confirmed the roles of functional genes of V(V) reduction (napA and nirK) and SO42- reduction (dsrA) in such biological processes. This study provides a novel route to sustainable V(V) remediation in aquifers, with synchronous recovery of vanadium resources without rebound.

Anaerobic removal of contaminants of emerging concern in municipal wastewater: Eco-toxicological risk evaluation and strategic selection of optimal treatment

In the last decades, the interest for anaerobic process as a mainstream treatment of municipal wastewater increased due to the development of high-rate anaerobic bioreactors able to achieve removal kinetics comparable to the aerobic ones. Moreover, they have the additional advantages of energy production, nutrient recovery and reduced excess sludge yield, which are interesting features in the frame of sustainability wastewater treatment goals. These appealing factors increased the research demand to evaluate the potential of the anaerobic removal for contaminants of emerging concern (CECs) in municipal wastewater. However, despite the growing interest for the subject, literature is still fragmentary and reviews are mainly focused on specific technologies and target compounds or groups of compounds. We propose this review with the main objectives of presenting the state of knowledge, the performances of anaerobic systems for CECs' removal and, more important, to give the reader guidelines for optimal treatment selection. In the first part, a general overview of the investigated technologies at different scale, with a special focus on the recently proposed enhancements, is presented. Collected data are analysed to select the target CECs and the analysis results employed to define the optimal technological solution for their removal. A first novelty element of the paper is the original procedure for contaminant selection consisting of a risk assessment tool for CECs, based on their frequency of detection, concentration and potential for biosorption in wastewater treatment plants. Data of selected target CECs are combined with compound and technology performance data to implement a flowchart tool to evaluate the optimal treatment strategy, which constitute another, even more important, novelty element of this study.

The fate of sulfamethoxazole and trimethoprim in a micro-aerated anaerobic membrane bioreactor and the occurrence of antibiotic resistance in the permeate

This study investigates the effects, conversions, and resistance induction, following the addition of 150 μg·L-1 of two antibiotics, sulfamethoxazole (SMX) and trimethoprim (TMP), in a laboratory-scale micro-aerated anaerobic membrane bioreactor (MA-AnMBR). TMP and SMX were removed at 97 and 86%, indicating that micro-aeration did not hamper their removal. These antibiotics only affected the pH and biogas composition of the process, with a significant change in pH from 7.8 to 7.5, and a decrease in biogas methane content from 84 to 78%. TMP was rapidly adsorbed onto the sludge and subsequently degraded during the long solids retention time of 27 days. SMX adsorption was minimal, but the applied hydraulic retention time of 2.6 days was sufficiently long to biodegrade SMX. The levels of three antibiotic-resistant genes (ARGs) (sul1, sul2, and dfrA1) and one mobile genetic element biomarker (intI1) were analyzed by qPCR. Additions of the antibiotics increased the relative abundances of all ARGs and intI1 in the MA-AnMBR sludge, with the sul2 gene folding 15 times after 310 days of operation. The MA-AnMBR was able to reduce the concentration of antibiotic-resistant bacteria (ARB) in the permeate by 3 log.

Impact of graphene oxide addition on pharmaceuticals removal in anaerobic membrane bioreactor

The addition of conductive materials to the anaerobic digestion bioreactor was suggested to enhance microbial activity. In the present work, an anaerobic membrane bioreactor treating municipal wastewater was operated for 385 days. The impact of different graphene oxide concentrations on the removal target pharmaceuticals and microbial community dynamics was investigated. The addition of graphene oxide did not impact the reactor stability, whereas the removals of antibiotics (e.g., trimethoprim and metronidazole) were enhanced. A shift in the microbial community was detected after the addition of 50-900 mg L^-1 of graphene oxide, with the proliferation hydrogenotrophic methanogens. The proliferation of syntrophic microorganisms may indicate interactions via direct interspecific electron transfer. The obtained results suggest that the addition of graphene oxide at low mg L^-1 concentrations to an anaerobic membrane bioreactor may be considered to improve the removal of antibiotics from municipal wastewater.

Anaerobic membrane bioreactor for carbon-neutral treatment of industrial wastewater containing N, N-dimethylformamide: Evaluation of electricity, bio-energy production and carbon emission

The feasibility of anaerobic membrane bioreactor (AnMBR) for the treatment of N, N-dimethylformamide (DMF)-containing wastewater was theoretically compared with the conventional activated sludge (CAS) process in this study. The electricity consumption and expenditure, bio-energy production and CO₂ emission were investigated using the operational results of a lab-scale AnMBR operated in a long-term operation. The AnMBR was capable of producing bio-methane from wastewater and generated 3.45 kWh/m³ of electricity as recovered bio-energy while the CAS just generated 1.17 kWh/m³ of electricity from the post-treatment of excessive sludge disposal. The large quantity of bio-methane recovered by the AnMBR can also be sold as sustainable bioresource for the use of household natural gas with a theoretical profit gain of 29,821 US$/year, while that of the CAS was unprofitable. The AnMBR was also demonstrated to significantly reduce the carbon emission by obtaining a theoretical negative CO₂ production of -2.34 kg CO₂/m³ with the recycle of bio-energy while that for the CAS was 4.50 kg CO₂/m³. The results of this study demonstrate that the AnMBR process has promising potential for the carbon-neutral treatment of high-strength DMF-containing wastewater in the future.

Anaerobic membrane bioreactors for pharmaceutical-laden wastewater treatment: A critical review

Pharmaceuticalsare a diverse group of chemical compounds widely used for prevention and treatment of infectious diseases in both humans and animals. Pharmaceuticals, either in their original or metabolite form, find way into the wastewater treatment plants (WWTPs) from different sources. Recently, anaerobic membrane bioreactors (AnMBR) has received significant research attention for the treatment of pharmaceuticals in various wastewater streams. This review critically examines the behaviour and removal of a wide array of pharmaceuticals in AnMBR with primary focus on their removal efficiencies and mechanisms, critical influencing factors, and the microbial community structures. Subsequently, the inhibitory effects of pharmaceuticals on the performance of AnMBR and membrane fouling are critically discussed. Furthermore, the imperative role of membrane biofouling layer and its components in pharmaceuticals removal is highlighted. Finally, recent advancements in AnMBR configurations for membrane fouling control and enhanced pharmaceuticals removal are systemically discussed.